Lion Biotechnologies Inc

(GNBPD)

By |

Profile

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. It's lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma.

Contact Information

Website: www.iovance.com
Email: sara.pellegrino@iovance.com
Main Phone: +1 650 260-7120
Address: 999 Skyway Road
Address 2: Suite 150
State: CA
City / Town: San Carlos
Country: US
Postal Code: 94070

Issuer Information

Exchange: OTO
CEO: Maria Fardis
Employees: 148
NAICS: Medicinal and Botanical Manufacturing(325411)

Equities News

Profile

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. It's lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma.

Contact Information

Website: www.iovance.com
Email: sara.pellegrino@iovance.com
Main Phone: +1 650 260-7120
Address: 999 Skyway Road
Address 2: Suite 150
State: CA
City / Town: San Carlos
Country: US
Postal Code: 94070

Issuer Information

Exchange: OTO
CEO: Maria Fardis
Employees: 148
NAICS: Medicinal and Botanical Manufacturing(325411)

Equities News

$ 5.80 $ 0. (0.00%)
Last Price 5.80 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 5.80
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap 849.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 146,443,212.00 EPS (TTM) -1.93 PE Ratio N/A Exchange OTCPK
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 18 18 18 18
Low Target Price Estimate 13 13 13 13
Mean Target Price Estimate 15.4 15.4 15.4 15.4
Standard Deviation 1.82 1.82 1.82 1.82
Date of Most Recent Estimate 07/08/16 07/08/16 07/08/16 07/08/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1